Aflibercept in Polypoidal Choroidal Vasculopathy
NCT02120950
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
333
Enrollment
INDUSTRY
Sponsor class
Conditions
Neovascular Macular Degeneration
Interventions
DRUG:
Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
OTHER:
Visudyne
Sponsor
Bayer
Collaborators
[object Object]